Loading…
Deepak Chemtex (BSE 544036)₹93.45+1.25%Specialty Chemicals
In the Sep 2026 quarter (consolidated), Deepak Chemtex reported sales of ₹40.07 Cr, up 29.1% from Sep 2025, and net profit of ₹6.01 Cr, up 49.9% year on year. For the year to Mar 2026, sales were ₹67.07 Cr and net profit ₹8.02 Cr.
Company filings, consolidated accounts; latest reported quarter Sep 2026
| Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|
| Sales | 22.01 | 28.03 | 39.05 | 41.05 | 31.03 | 37.04 | 40.07 |
| Expenses | 18.07 | 24.09 | 31.09 | 32.14 | 25.08 | 31.12 | 33.10 |
| Operating Profit | 3.99 | 3.99 | 7.97 | 8.97 | 5.97 | 4.99 | 6.97 |
| OPM % | 19.0% | 14.0% | 19.9% | 20.9% | 20.0% | 14.0% | 17.0% |
| Other Income | 0.00 | 0.99 | 0.99 | 1.99 | 0.99 | 1.99 | 1.99 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.00 | 1.01 | 1.01 | 1.01 | 1.01 | 1.01 |
| Profit before tax | 4.01 | 4.01 | 7.02 | 9.03 | 6.02 | 6.02 | 8.03 |
| Tax % | 24.9% | 29.9% | 25.0% | 25.9% | 21.9% | 31.0% | 17.0% |
| Net Profit | 3.01 | 3.01 | 6.01 | 7.02 | 4.01 | 4.01 | 6.01 |
| EPS (Rs) | 3.92 | 2.64 | 5.12 | 6.30 | 3.92 | 3.69 | 5.73 |
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Sales | 54.06 | 46.03 | 49.05 | 79.10 | 67.07 |
| Expenses | 48.20 | 39.12 | 41.15 | 63.27 | 56.22 |
| Operating Profit | 5.98 | 7.97 | 7.97 | 16.95 | 10.97 |
| OPM % | 11.0% | 17.0% | 16.0% | 20.9% | 17.0% |
| Other Income | 0.00 | 0.99 | 0.99 | 2.99 | 2.99 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 1.01 | 1.01 | 0.99 | 2.01 | 3.01 |
| Profit before tax | 6.02 | 8.03 | 8.02 | 17.05 | 12.05 |
| Tax % | 24.9% | 24.9% | 26.9% | 24.9% | 27.0% |
| Net Profit | 4.01 | 6.01 | 6.01 | 13.03 | 8.02 |
| EPS (Rs) | — | — | 5.52 | 11.56 | 7.82 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Equity Capital | 0.51 | 0.51 | 11.01 | 11.00 | 11.00 |
| Reserves | 9.02 | 15.00 | 31.00 | 43.95 | 52.98 |
| Borrowings | 1.99 | 1.01 | 1.99 | 0.99 | 0.99 |
| Other Liabilities | 5.97 | 6.96 | 6.96 | 10.95 | 9.95 |
| Total Liabilities | 16.99 | 23.98 | 50.96 | 66.89 | 74.92 |
| Fixed Assets | 3.01 | 4.01 | 8.01 | 13.03 | 17.03 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 5.99 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 13.98 | 18.97 | 42.95 | 53.86 | 51.90 |
| Inventories | 2.14 | 4.28 | 6.55 | 11.18 | 20.50 |
| Trade receivables | 8.46 | 11.17 | 14.39 | 20.22 | 16.44 |
| Cash & equivalents | 0.41 | 0.99 | 19.66 | 5.62 | 4.01 |
| Total Assets | 16.99 | 23.98 | 50.96 | 66.89 | 74.92 |
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Cash from operating activity | 0.99 | 2.99 | 1.99 | 2.99 | 5.99 |
| Cash from investing activity | −0.99 | −2.01 | −4.01 | −15.99 | −7.99 |
| Cash from financing activity | 0.00 | −1.01 | 20.05 | −1.01 | 0.00 |
| Net cash flow | 0.00 | 0.99 | 18.97 | −13.98 | −1.99 |
| Capex | 0.88 | 2.16 | 3.92 | 8.19 | 12.05 |
| Free cash flow | 0.00 | 1.01 | −2.01 | −5.01 | −6.02 |
| CFO / OP % | 36.0% | 70.9% | 51.0% | 38.0% | 86.0% |
| Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|
| Debtor days | 57 | 88 | 107 | 93 | 89 |
| Inventory days | 22 | 55 | 83 | 83 | 177 |
| Days payable | 36 | 53 | 50 | 46 | 67 |
| Cash conversion cycle | 41 | 88 | 138 | 128 | 197 |
| Working capital days | 43 | 82 | 110 | 125 | 169 |
| ROCE % | — | 58.0% | 28.0% | 34.0% | 19.1% |
For the Sep 2026 quarter, Deepak Chemtex reported sales of ₹40.07 Cr, up 29.1% year on year and net profit of ₹6.01 Cr, up 49.9% year on year. The operating margin was 17.0%.
Deepak Chemtex's sales for the year to Mar 2026 were ₹67.07 Cr.
Net profit for the year to Mar 2026 was ₹8.02 Cr. Earnings per share over the same trailing period were ₹7.82.
Deepak Chemtex reported borrowings of ₹0.99 Cr at Mar 2026, against cash and equivalents of ₹4.01 Cr.
Cash from operations was ₹5.99 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹6.02 Cr.